Translating glucose variability metrics into the clinic via continuous glucose monitoring: A graphical user interface for diabetes evaluation (CGM-GUIDE©)

Diabetes Technology and Therapeutics

Volumn 13, Issue 12, 2011, Pages 1241-1248

  Rawlings, Renata A ^a   Shi, Hang ^a   Yuan, Lo Hua ^a   Brehm, William ^b   Pop Busui, Rodica ^b,c   Nelson, Patrick W ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALYTICAL PARAMETERS; ARTICLE; BLOOD GLUCOSE MONITORING; CLINICAL ARTICLE; CLINICAL ASSESSMENT TOOL; CLINICAL EVALUATION; CLINICAL PRACTICE; CONTINUOUS GLUCOSE MONITORING GRAPHICAL USER INTERFACE FOR DIABETES EVALUATION; CONTROLLED STUDY; GLUCOSE VARIABILITY; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MATHEMATICAL ANALYSIS; PLOTS AND CURVES; PRIORITY JOURNAL; QUANTITATIVE STUDY; REFERENCE VALUE; STATISTICAL ANALYSIS;

BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; DATA INTERPRETATION, STATISTICAL; DIABETES MELLITUS, TYPE 1; HUMANS; NOMOGRAMS;

EID: 82455204674     PISSN: 15209156     EISSN: 15578593     Source Type: Journal    
DOI: 10.1089/dia.2011.0099     Document Type: Article

References (60)

1. Monnier L, Mas E, Ginet C, Michel F, Villon L, Cristol J-P, Colette C: Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA 2006;295:1681-1687.
2. Kilpatrick ES, Rigby AS, Atkin SL: Effect of glucose variability on the long-term risk of microvascular complications in type 1 diabetes. Diabetes Care 2009;32:1901-1903.
3. Zaccardi F, Pitocco D, Ghirlanda G: Glycemic risk factors of diabetic vascular complications: the role of glycemic variability. Diabetes Metab Res Rev 2009;25:199-207.
4. Service FJ, Molnar GD, Rosevear JW, Ackerman E, Gatewood LC, Taylor WF: Mean amplitude of glycemic excursions, a measure of diabetic instability. Diabetes 1970;19:644-655.
5. Molnar GD, Taylor WF, Ho MM: Day to day variation of continuously monitored glycemia: a further measure of diabetic instability. Diabetologia 1972;8:342-348.
6. McDonnell CM, Donath SM, Vidmar SI, Werther GA, Cameron FJ: A novel approach to continuous glucose analysis utilizing glycemic variation. Diabetes Technol Ther 2005;7: 253-263. (Pubitemid 40586369)
7. Schlichtkrull J, Munck O, Jersild M: The M-value, an index of blood-sugar control in diabetics. Acta Med Scand 1965;177: 95-102.
8. Kovatchev BP, Otto E, Cox D, Gonder-Frederick L, Clarke W: Evaluation of a new measure of blood glucose variability in diabetes. Diabetes Care 2006;29:2433-2438. (Pubitemid 44912248)
9. Hill NR, Hindmarsh PC, Stevens RJ, Stratton IM, Levy JC, Matthews DR: A method for assessing quality of control from glucose profiles. Diabet Med 2007;24:753-758. (Pubitemid 47012121)
10. Wojcicki JM: "J"-index. A new proposition of the assessment of current glucose control in diabetic patients. Horm Metab Res 1995;27:41-42.
11. Cameron FJ, Donath SM, Baghurst PA: Measuring glycaemic variation. Curr Diabetes Rev 2010;6:17-26.
12. Fox LA, Beck RW, Xing D: Variation of interstitial glucose measurements assessed by continuous glucose monitors in healthy, nondiabetic individuals. Diabetes Care 2010;33:1297-1299.
13. Fritzsche G, Kohnert KD, Heinke P, Vogt L, Salzsieder E: The use of a computer program to calculate the mean amplitude of glycemic excursions. Diabetes Technol Ther 2011;13:319-325.
14. Baghurst PA: Calculating the mean amplitude of glycemic excursions from continuous glucose monitoring data: an automated algorithm. Diabetes Technol Ther 2011;13:296-302.
15. Baghurst PA, Rodbard D, Cameron FJ: The minimum frequency of glucose measurements from which glycemic variation can be consistently assessed. J Diabetes Sci Technol 2010;4:1382-1385.
16. Salardi S, Zucchini S, Santoni R, Ragni L, Gualandi S, Cicognani A, Cacciari E: The glucose area under the profiles obtained with continuous glucose monitoring system relationships with HbA1c in pediatric type 1 diabetic patients. Diabetes Care 2002;25:1840-1844. (Pubitemid 41071097)
17. Rodbard D, Bailey T, Jovanovic L, Zisser H, Kaplan R, Garg SK: Improved quality of glycemic control and reduced glycemic variability with use of continuous glucose monitoring. Diabetes Technol Ther 2009;11:717-723.
18. Siegelaar SE, Holleman F, Hoekstra JB, DeVries JH: Glucose variability; does it matter? Endocr Rev 2010;31:171-182.
19. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 1993; 329:977-986.
20. Kilpatrick ES, Rigby AS, Atkin SL: The effect of glucose variability on the risk of microvascular complications in type 1 diabetes. Diabetes Care 2006;29:1486-1490. (Pubitemid 44127568)
21. Siegelaar SE, Kilpatrick ES, Rigby AS, Atkin SL, Hoekstra JB, Devries JH: Glucose variability does not contribute to the development of peripheral and autonomic neuropathy in type 1 diabetes: data from the DCCT. Diabetologia 2009;52:2229-2232.
22. Bruttomesso D, Crazzolara D, Maran A, Costa, S, Dal Pos M, Girelli A, Lepore G, Aragona M, Iori E, Valentini U, Del Prato S, Tiengo A, Buhr A, Trevisan R, Baritussio A: In Type 1 diabetic patients with good glycaemic control, blood glucose variability is lower during continuous subcutaneous insulin infusion than during multiple daily injections with insulin glargine. Diabet Med 2008;25:326-332. (Pubitemid 351322703)
23. Kilpatrick ES, Rigby AS, Goode K, Atkin SL: Relating mean blood glucose and glucose variability to the risk of multiple episodes of hypoglycaemia in type 1 diabetes. Diabetologia 2007;50:2553-2561. (Pubitemid 350060641)
24. White NH, Chase HP, Arslanian S, Tamborlane WV: Comparison of glycemic variability associated with insulin glargine and intermediate-acting insulin when used as the basal component of multiple daily injections for adolescents with type 1 diabetes. Diabetes Care 2009;32:387-393.
25. Dossett LA, Cao H, Mowery NT, Dortch MJ, Morris JM Jr, May AK: Blood glucose variability is associated with mortality in the surgical intensive care unit. Am Surg 2008;74: 679-685; discussion 685.
26. Egi M, Bellomo R, Stachowski E, French CJ, Hart G: Variability of blood glucose concentration and short-term mortality in critically ill patients. Anesthesiology 2006;105:244-252. (Pubitemid 44148168)
27. Krinsley JS: Glycemic variability: a strong independent predictor of mortality in critically ill patients. Crit Care Med 2008;36:3008-3013.
28. Hirshberg E, Larsen G, Van Duker H: Alterations in glucose homeostasis in the pediatric intensive care unit: hyperglycemia and glucose variability are associated with increased mortality and morbidity. Pediatr Crit Care Med 2008;9: 361-366.
29. Wintergerst KA, Buckingham B, Gandrud L, Wong BJ, Kache S, Wilson DM: Association of hypoglycemia, hyperglycemia, and glucose variability with morbidity and death in the pediatric intensive care unit. Pediatrics 2006;118:173-179. (Pubitemid 46071160)
30. Czerwoniuk D, Fendler W, Walenciak L, Wojciech M: Gly-Culator: a glycemic variability calculation tool for continuous glucose monitoring data. J Diabetes Sci Technol 2011;5: 447-451.
31. Monnier L, Mas E, Ginet C, Michel F, Villon L, Cristol J-P, Colette C: Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA 2006;295:1681-1687.
32. Kilpatrick ES, Rigby AS, Atkin SL: Effect of glucose variability on the long-term risk of microvascular complications in type 1 diabetes. Diabetes Care 2009;32:1901-1903.
33. Zaccardi F, Pitocco D, Ghirlanda G: Glycemic risk factors of diabetic vascular complications: the role of glycemic variability. Diabetes Metab Res Rev 2009;25:199-207.
34. Service FJ, Molnar GD, Rosevear JW, Ackerman E, Gatewood LC, Taylor WF: Mean amplitude of glycemic excursions, a measure of diabetic instability. Diabetes 1970;19:644-655.
35. Molnar GD, Taylor WF, Ho MM: Day to day variation of continuously monitored glycemia: a further measure of diabetic instability. Diabetologia 1972;8:342-348.
36. McDonnell CM, Donath SM, Vidmar SI, Werther GA, Cameron FJ: A novel approach to continuous glucose analysis utilizing glycemic variation. Diabetes Technol Ther 2005;7: 253-263. (Pubitemid 40586369)
37. Schlichtkrull J, Munck O, Jersild M: The M-value, an index of blood-sugar control in diabetics. Acta Med Scand 1965;177: 95-102.
38. Kovatchev BP, Otto E, Cox D, Gonder-Frederick L, Clarke W: Evaluation of a new measure of blood glucose variability in diabetes. Diabetes Care 2006;29:2433-2438. (Pubitemid 44912248)
39. Hill NR, Hindmarsh PC, Stevens RJ, Stratton IM, Levy JC, Matthews DR: A method for assessing quality of control from glucose profiles. Diabet Med 2007;24:753-758. (Pubitemid 47012121)
40. Wojcicki JM: "J"-index. A new proposition of the assessment of current glucose control in diabetic patients. Horm Metab Res 1995;27:41-42.
41. Cameron FJ, Donath SM, Baghurst PA: Measuring glycaemic variation. Curr Diabetes Rev 2010;6:17-26.
42. Fox LA, Beck RW, Xing D: Variation of interstitial glucose measurements assessed by continuous glucose monitors in healthy, nondiabetic individuals. Diabetes Care 2010;33:1297-1299.
43. Fritzsche G, Kohnert KD, Heinke P, Vogt L, Salzsieder E: The use of a computer program to calculate the mean amplitude of glycemic excursions. Diabetes Technol Ther 2011;13:319-325.
44. Baghurst PA: Calculating the mean amplitude of glycemic excursions from continuous glucose monitoring data: an automated algorithm. Diabetes Technol Ther 2011;13:296-302.
45. Baghurst PA, Rodbard D, Cameron FJ: The minimum frequency of glucose measurements from which glycemic variation can be consistently assessed. J Diabetes Sci Technol 2010;4:1382-1385.
46. Salardi S, Zucchini S, Santoni R, Ragni L, Gualandi S, Cicognani A, Cacciari E: The glucose area under the profiles obtained with continuous glucose monitoring system relationships with HbA1c in pediatric type 1 diabetic patients. Diabetes Care 2002;25:1840-1844. (Pubitemid 41071097)
47. Rodbard D, Bailey T, Jovanovic L, Zisser H, Kaplan R, Garg SK: Improved quality of glycemic control and reduced glycemic variability with use of continuous glucose monitoring. Diabetes Technol Ther 2009;11:717-723.
48. Siegelaar SE, Holleman F, Hoekstra JB, DeVries JH: Glucose variability; does it matter? Endocr Rev 2010;31:171-182.
49. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 1993; 329:977-986.
50. Kilpatrick ES, Rigby AS, Atkin SL: The effect of glucose variability on the risk of microvascular complications in type 1 diabetes. Diabetes Care 2006;29:1486-1490. (Pubitemid 44127568)
51. Siegelaar SE, Kilpatrick ES, Rigby AS, Atkin SL, Hoekstra JB, Devries JH: Glucose variability does not contribute to the development of peripheral and autonomic neuropathy in type 1 diabetes: data from the DCCT. Diabetologia 2009;52:2229-2232.
52. Bruttomesso D, Crazzolara D, Maran A, Costa, S, Dal Pos M, Girelli A, Lepore G, Aragona M, Iori E, Valentini U, Del Prato S, Tiengo A, Buhr A, Trevisan R, Baritussio A: In Type 1 diabetic patients with good glycaemic control, blood glucose variability is lower during continuous subcutaneous insulin infusion than during multiple daily injections with insulin glargine. Diabet Med 2008;25:326-332. (Pubitemid 351322703)
53. Kilpatrick ES, Rigby AS, Goode K, Atkin SL: Relating mean blood glucose and glucose variability to the risk of multiple episodes of hypoglycaemia in type 1 diabetes. Diabetologia 2007;50:2553-2561. (Pubitemid 350060641)
54. White NH, Chase HP, Arslanian S, Tamborlane WV: Comparison of glycemic variability associated with insulin glargine and intermediate-acting insulin when used as the basal component of multiple daily injections for adolescents with type 1 diabetes. Diabetes Care 2009;32:387-393.
55. Dossett LA, Cao H, Mowery NT, Dortch MJ, Morris JM Jr, May AK: Blood glucose variability is associated with mortality in the surgical intensive care unit. Am Surg 2008;74: 679-685; discussion 685.
56. Egi M, Bellomo R, Stachowski E, French CJ, Hart G: Variability of blood glucose concentration and short-term mortality in critically ill patients. Anesthesiology 2006;105:244-252. (Pubitemid 44148168)
57. Krinsley JS: Glycemic variability: a strong independent predictor of mortality in critically ill patients. Crit Care Med 2008;36:3008-3013.
58. Hirshberg E, Larsen G, Van Duker H: Alterations in glucose homeostasis in the pediatric intensive care unit: hyperglycemia and glucose variability are associated with increased mortality and morbidity. Pediatr Crit Care Med 2008;9: 361-366.
59. Wintergerst KA, Buckingham B, Gandrud L, Wong BJ, Kache S, Wilson DM: Association of hypoglycemia, hyperglycemia, and glucose variability with morbidity and death in the pediatric intensive care unit. Pediatrics 2006;118:173-179. (Pubitemid 46071160)
60. Czerwoniuk D, Fendler W, Walenciak L, Wojciech M: Gly-Culator: a glycemic variability calculation tool for continuous glucose monitoring data. J Diabetes Sci Technol 2011;5: 447-451.